on either IL-3 or GM-CSF, reflecting the ability of these cyto-
kines to stimulate early progenitor and immature cells. Further studies also suggested that non-lineage specific hormones such as insulin and insulin-like growth factor (IGF-I) can synergistically stimulate growth of factor-dependent leukemia Introduction cells lines. 1 Thus, the establishment of factor-dependent cell lines allowed for the continuous growth of leukemic cells that Mature blood cells have a finite lifespan and must be replenwere previously eliminated during selection in standard ished throughout adult life by the continued activity of hemaculture medium. topoietic stem and progenitor cells that are operationally
These factor-dependent cell lines are important models for defined by their capacity to repopulate lymphoid and myeloid cytokine signal transduction as well as proliferative responses lineages. For these stem and progenitor cells to proliferate and and differentiation. 2 Withdrawal of the supporting growth facmature in multiple lineages, coordinated support by a multitor commonly leads to cell death within a few days in most tude of cytokines is required. The complexity of hematopocell lines. This rapid cell death occurs by an active cellular ietic cells presents difficulties for the identification of cytoprocess (apoptosis) that can be suppressed by new addition kines with specific effects on certain types of cells and at the of growth factors. 3 Most of these cell lines showed a growth various stages of activation, proliferation or differentiation.
response to several different cytokines; quite heterogeneous Cultures seeded with peripheral blood or bone marrow patterns of response were evident with no two lines exhibiting samples develop adherent layers that are composed of a comthe same response phenotype. human variant: (DSM ACC 247); TF-1 (DSM ACC 334). Cell lines were grown at 37°C in a humidified atmosphere of air containing 5% CO 2 .
• 5637 CM (5637 human bladder carcinoma cell line conditioned medium; 10% vol; containing c. 42 ng/ml G-CSF, The basal growth media (Table 1 ; from Gibco BRL, Eggenstein, Germany) were supplemented with 5-20% heat-2.1 ng/ml GM-CSF, 110 pg/ml M-CSF, 120 pg/ml SCF);
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• bFGF (basic fibroblast growth factor; 50 ng/ml; 0.4-inactivated (at 56°C for 45 min) fetal bovine serum (FBS; from Sigma, Deisenhofen, Germany). Freedom of myco-1.0 × 10 7 U/mg; R&D Systems, Wiesbaden, Germany); • CNTF (ciliary neurotrophic factor; 250 ng/ml; R&D); plasma contamination was determined after thawing the cell lines by cultivation on agar and by frequent DAPI staining.
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• EGF (epidermal growth factor; 10 ng/ml; Ͼ2-4 × 10 7 U/mg; Pharma Biotechnologie, Hannover (PBH), Germany); Cultures were passaged according to standard procedures: spent culture medium of these suspension cell lines was
• EPO (erythropoietin; 5 U/ml; Ͼ70 000 U/mg; Boehringer Mannheim, Mannheim, Germany); exchanged at regular intervals (usually after 24-48 h). 5 All cell lines were examined daily in their culture vessels under an
• FLT3L (flt3-ligand; 100 ng/ml; kindly provided by Dr S Lyman, Immunex, Seattle, WA, USA); inverted microscope. Cells were harvested and used for experiments in their logarithmic growth phase with viabilities
• G-CSF (granulocyte colony-stimulating factor; 10 ng/ml; Ͼ1.0 × 10 7 U/mg; Boehringer Mannheim); exceeding 90% as determined by trypan blue dye exclusion. The cell counts and viabilities were examined in standard
• GM-CSF (granulocyte-macrophage CSF; 10 ng/ml; Ͼ1.0 × 10 7 U/mg; Boehringer Mannheim); hematocytometers.
As all cell lines used in this project are constitutively growth • HGF (hepatocyte growth factor; 50 ng/ml; R&D);
• IFN-␣ (interferon-␣; 10 ng/ml; 2 × 10 8 U/mg; PBH); factor-dependent, their culture media had to be supplemented either with conditioned medium from the cell line 5637 (at • IFN-␤ (10 ng/ml; 2 × 10 8 U/mg; PBH); • IFN-␥ (10 ng/ml; Ͼ2.0 × 10 7 U/mg; Boehringer Mannheim); 10-20% v/v) or with recombinant cytokines. The cell line 5637 (DSM ACC 35) 24, 25 has been maintained in this institute • IGF-I (insulin-like growth factor I; 100 ng/ml; Boehringer Mannheim); for several years. It is serially passaged by trypsinization in the presence of EDTA and grows rapidly to form an adherent • IGF-II (100 ng/ml; Boehringer Mannheim);
• IL-1␣ (interleukin-1␣; 10 ng/ml; Ͼ5.0 × 10 7 U/mg; Boehmonolayer in plastic tissue culture flasks. Routinely, 5637 cells are cultured in RPMI 1640 medium supplemented with ringer Mannheim); • IL-2 (10 ng/ml; Ͼ2.0 × 10 6 U/mg; Boehringer Mannheim); 10% FBS. After 48-72 h following seeding of freshly thawed and washed cells, 5637 cell line-conditioned medium
• IL-3 (10 ng/ml; Ͼ1.0 × 10 7 U/mg; Boehringer Mannheim); • IL-4 (10 ng/ml; Ͼ5.0 × 10 5 U/mg; Boehringer Mannheim); (henceforth termed 5637 CM) was harvested, cells and cell debris were removed by centrifugation (10 min, 200 g), and
• IL-5 (10 ng/ml; Pepro Tech, London, UK);
• IL-6 (10 ng/ml; Ͼ1.0 × 10 8 U/mg; Boehringer Mannheim); the resulting clear supernatant was passed through a 0.2 m filter and was stored at −20°C until use. Recombinant granulo-
• IL-7 (20 ng/ml; Ͼ5.0 × 10 6 U/mg; Boehringer Mannheim); • IL-8 (100 ng/ml; Ͼ1.0 × 10 4 U/mg; Boehringer Mannheim); cyte-macrophage colony-stimulating (GM-CSF) and stem cell factor (SCF) were used at 1-5 ng/ml and 50 ng/ml, respect-
• IL-9 (10 ng/ml; R&D); • IL-10 (100 ng/ml; 5 × 10 5 U/mg; PBH); ively, and were kindly provided by Dr A Mire-Sluis (London, UK).
• IL-11 (10 ng/ml; 2.5-5.0 × 10 6 U/mg; R&D); • IL-12 (10 ng/ml; R&D); • IL-13 (10 ng/ml; R&D); • IL-15 (10 ng/ml; R&D);
Proliferation assay
• LIF (leukemia inhibitory factor; 25 ng/ml; Ͼ1.0 × 10 7 U/mg; Boehringer Mannheim); The proliferative response of the cell lines to the various effectors was examined by cell counting in hematocytometers or
• MCP-1 (monocyte chemotactic protein-1; 25 ng/ml; R&D);
• M-CSF (macrophage-CSF; 50 ng/ml; 2.0-5.0 × 10 6 U/mg; standard 3 H-thymidine incorporation and ␤-scintillation counting (LKB 1209 Rackbeta; Pharmacia, Freiburg, Germany). The R&D); ␣-MEM, ␣-minimal essential medium. Cytokines:
+1-5 ng/ml GM-CSF;
+50 ng/ml SCF; +10-20% (vol) 5637 CM. Serum:
+10%
human AB serum. 
• MIP-1␣ (macrophage inflammatory protein-1␣; 50 ng/ml; • TPO (thrombopoietin; 100 U/ml = c. 50 ng/ml; kindly provided by Dr DC Foster, Zymogenetics, Seattle, WA, USA). 2.0-5.0 × 10 5 U/mg; R&D); • NGF (nerve growth factor; 10 ng/ml; R&D); • OSM (oncostatin M; 10 ng/ml; 0.33-0.66 × 10 7 U/mg; R&D);
• PDGF (platelet-derived growth factor; 10 ng/ml; PBH);
Results and discussion • PIXY-321 (fusion protein of IL-3 and GM-CSF; 10 ng/ml; kindly provided by Immunex); • RANTES ('regulated upon activation, normal T cell Autonomous growth of malignant hematopoietic cells is often driven by the same factors stimulating normal cell proliferexpressed and secreted'; 50 ng/ml; Pepro);
• SCF (stem cell factor; 50 ng/ml; 0.5-1.0 × 10 6 U/mg; R&D); ation. Leukemic cell proliferation may occur in autocrine loops with the neoplastic cells producing their own growth • TGF-␤1 (transforming growth factor-␤; 50 ng/ml; 1-2 × 10 7 U/mg; PBH); factors. Growth can also take place in paracrine circuits, whereby growth factors are released by surrounding cells.
• TNF-␣ (tumor necrosis factor-␣; 10 ng/ml; Ͼ2.0 × 10 6 U/mg; Biermann, Bad Nauheim, Germany); Continuous human leukemia cell lines represent powerful tools to investigate these mechanisms. 26, 27 Most lines grow • TNF-␤ (= lymphotoxin; 10 ng/ml; Ͼ1.0 × 10 8 U/mg; Boehringer Mannheim) autonomously independent of externally added growth stimuli 
Stimulation index (SI) comparing the cytokine-exposed cells directly with the respective control cells (grown without the specific cytokine, but in standard medium containing FBS) under identical conditions. Stimulatory effects: +, SI 2-5; ++, SI 5-10; +++, SI Ͼ10. (except for FBS). Recently, various myeloid leukemia-derived conditions, cytokine-independent subclones may grow out within 1-2 months. cell lines have been established that are constitutively dependent on the addition of cytokines to the culture. Here we anaIn order to examine the mitogenic or inhibitory effects of hematopoietic cytokines on these cell lines, aliquots of cells lyzed 19 absolutely growth factor-dependent leukemia cell lines with myelomonocytic, erythroid or megakaryocytic were exposed to a panel of 41 cytokines in a short-term (48 h) 3 H-thymidine uptake assay. Cytokines were used at optimal phenotypes which were derived from AML or CML in blast crisis.
concentrations as described in the literature or according to own empirical experience with these reagents. A proliferative All cell lines used in this study (Table 1) are constitutively and absolutely dependent on the exogenous supply of growth response was considered positive (stimulatory effect) when the stimulation index SI was Ͼ2; inhibition of proliferation factors in order to maintain proliferation and survival; in the absence of added growth factors the cells perish undergoing (inhibitory effect) was defined as significant with an SI Ͻ0.5.
We did not test the effects of combinations of cytokines which apoptosis and die within 1-2 weeks (two examples are shown in Figure 1 ). However, under suboptimal culture and feeding might be additive or synergistic, and did not evaluate the effects of these cytokines on cell survival, differentiation, activation or other biological processes. For instance, the enhancement of cell survival actively suppressing the process of apoptosis is distinct from the stimulation of proliferation. 3 For the purpose of convenience, the cytokines and the cell lines are arranged in Table 2 in alphabetical order (and not according to common functional aspects of the cytokines or their receptors or to a common origin of the cell lines). Examples of detailed cytokine response profiles are given for the well-known and most often used growth factor-dependent cell lines, namely M-07e and TF-1 (Figure 2) .
It is of interest that none of the 19 cell lines displayed a cytokine response profile identical with that of another line. Furthermore, none of the cell lines responded to one or two factors only (minimally to at least five cytokines). The cell lines responding most often (positively) to these cytokines were UCSD/AML1 (to 19 different cytokines), HU-3 (n = 18), TF-1 (n = 17) and M-07e (n = 15). As all cell lines are normally While some cytokines elicited a proliferative response in 
